आईएसएसएन: 2475-7586
Venkat Rao J*
The comparatively privileged fact of nuclear medicine is that most of the scans and treatments are addressed as follow-up cases in the outpatient clinic, while experimental trials are typically handled following COVID-19 scanning in the inpatient department. An unfortunate truth, on the contrary, is that nuclear medicine lacks handheld SPECT and PET scanners, there is a continuous need to administer radiopharmaceuticals into patients so that the mobility of patients cannot be limited.